翰思艾泰-B(03378)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03378 翰思艾泰-B

未开盘 04-24 16:08:26

28.820

-2.400

-7.69%

最高31.360	最低28.000	成交量27.97万
今开30.960	昨收31.220	日振幅10.76%
总市值39.26亿	流通市值39.26亿	总股本1.36亿
成交额822.01万	换手率0.21%	流通股本1.36亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03378","market":"HK","secType":"STK","nameCN":"翰思艾泰-B","latestPrice":28.82,"timestamp":1777018106086,"preClose":31.22,"halted":0,"volume":279700,"delay":0,"changeRate":-0.07687379884689298,"floatShares":136218830,"shares":136218830,"eps":-1.2722565934840864,"marketStatus":"未开盘","change":-2.4,"latestTime":"04-24 16:08:26","open":30.96,"high":31.36,"low":28,"amount":8220064,"amplitude":0.107623,"askPrice":28.82,"askSize":800,"bidPrice":28.28,"bidSize":400,"shortable":0,"etf":0,"ttmEps":-1.2206786234779745,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777253400000},"marketStatusCode":0,"adr":0,"listingDate":1766419200000,"exchange":"SEHK","adjPreClose":31.22,"openAndCloseTimeList":[[1776994200000,1777003200000],[1777006800000,1777017600000]],"volumeRatio":3.0615148844891014,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"000905","market":"SZ","secType":"STK","nameCN":"厦门港务","latestPrice":10.64,"timestamp":1777014000000,"preClose":10.85,"halted":0,"volume":9231900,"delay":0,"premium":"+136.32"}},"requestUrl":"/m/hq/s/03378","defaultTab":"news","newsList":[{"id":"1168130602","title":"翰思艾泰-B：4月24日回购3.63万股股份，总额约105.77万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1168130602","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168130602?lang=zh_cn&edition=full","pubTime":"2026-04-24 20:56","pubTimestamp":1777035373,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技（武汉）股份有限公司4月24日公告，已于香港联交所场内回购36,300股股份，占回购前公司已发行股本约0.0267%。每股回购价格介乎28.00港元至31.36港元，合计涉资约105.77万港元。本次回购完成后，已发行股本为135,878,330股，库藏股数为340,500股，总股本规模保持在136,218,830股。公司于2026年2月12日通过购回授权，获准回购的总数为13,621,883股。公司确认已遵守香港联交所证券上市规则及相关法律法规。公告由董事长兼执行董事张发明签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰思艾泰-B：4月24日回购3.63万股股份，总额约105.77万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629841740","title":"翰思艾泰-B(03378)：在2026 AACR年会上发布四项核心临床前研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2629841740","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629841740?lang=zh_cn&edition=full","pubTime":"2026-04-24 20:56","pubTimestamp":1777035360,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰思艾泰-B 发布公告，公司在4月17日至22日于美国圣地亚哥举行的2026年美国癌症研究协会年会上，以壁报形式重磅发布四项核心临床前研究成果，进一步验证公司的研发实力与创新能力。上述积极的临床前数据为HX044的临床开发奠定了坚实基础，该产品目前正处于I期临床阶段。在临床前研究中，HX116展现出的活性优于其母体BsAb。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03378","BK1173","BK1161","BK1535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629438046","title":"翰思艾泰-B(03378)4月22日斥资98.85万港元回购3.12万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629438046","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629438046?lang=zh_cn&edition=full","pubTime":"2026-04-22 20:16","pubTimestamp":1776860197,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰思艾泰-B(03378)发布公告，于2026年4月22日该公司斥资98.85万港元回购3.12万股，回购价格为每股31.18-31.98港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432146.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03378","BK1161","BK1173","BK1535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128246554","title":"翰思艾泰-B4月22日回购3.12万股股份，耗资约98.85万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1128246554","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128246554?lang=zh_cn&edition=full","pubTime":"2026-04-22 20:16","pubTimestamp":1776860184,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技（武汉）股份有限公司于2026年4月22日公告称，公司当日于香港联交所场内回购31,200股股份，约占已发行股本的0.0229%。每股回购价介乎31.18港元至31.98港元，合计耗资988,500港元，折合约98.85万港元。购回授权由股东于2026年2月12日通过，可回购股份总数为13,621,883股，目前累计已回购277,200股，约占授权通过时已发行股本总数的0.2035%。公司确认已遵守香港联交所上市规则及所有相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰思艾泰-B4月22日回购3.12万股股份，耗资约98.85万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629035621","title":"翰思艾泰-B(03378.HK)4月21日耗资6.6万港元回购2100股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629035621","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629035621?lang=zh_cn&edition=full","pubTime":"2026-04-21 19:27","pubTimestamp":1776770824,"startTime":"0","endTime":"0","summary":"格隆汇4月21日丨翰思艾泰-B(03378.HK)公告，4月21日耗资6.6万港元回购2100股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260421/32160716.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","BK1535","BK1173","03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144801243","title":"翰思艾泰-B：4月21日回购2100股，涉资约6.65万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1144801243","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144801243?lang=zh_cn&edition=full","pubTime":"2026-04-21 19:07","pubTimestamp":1776769624,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技（武汉）股份有限公司（“翰思艾泰-B”，股票代码：03378）于2026年4月21日发布公告。公告显示，公司于当日通过香港联交所场内回购2100股，占当日前已发行股本约0.0015%，每股回购价介乎每股31.26港元至31.7港元，合计涉资约6.65万港元。\n本次回购完成后，公司已发行股本增至135,972,830股，库藏股数为246,000股。回购授权通过日期为2026年2月12日，公司可回购的总额为13,621,883股，已回购数量为246,000股。公司在公告中确认已遵守相关上市规则及适用法律法规。\n公告由公司董事长兼执行董事张发明签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰思艾泰-B：4月21日回购2100股，涉资约6.65万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131532424","title":"翰思艾泰-B回购2.3万股，涉资约68.46万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1131532424","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131532424?lang=zh_cn&edition=full","pubTime":"2026-04-17 19:46","pubTimestamp":1776426397,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技（武汉）股份有限公司于2026年4月17日发布公告，披露其在香港联合交易所场内回购普通股H股共23,000股，占公司已发行股本约0.017%。本次回购股份的价格区间介乎每股28.8港元至30.8港元，合共涉资约68.46万港元。本次回购完成后，公司已发行股份由原先的135,997,930股减少至135,974,930股，同时库藏股数增至243,900股，合计股本仍为136,218,830股。截至目前，公司累计购回243,900股，占购回授权通过当日已发行股本的0.1791%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628820533","title":"翰思艾泰-B(03378)4月17日耗资约68.46万港元回购2.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2628820533","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628820533?lang=zh_cn&edition=full","pubTime":"2026-04-17 19:46","pubTimestamp":1776426375,"startTime":"0","endTime":"0","summary":"翰思艾泰-B(03378)公布，2026年4月17日耗资约68.46万港元回购2.3万股股份。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_27.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_27.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430121.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1173","BK1535","03378","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115087712","title":"翰思艾泰-B：4月16日回购20,100股，耗资约59.07万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1115087712","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115087712?lang=zh_cn&edition=full","pubTime":"2026-04-16 20:06","pubTimestamp":1776341172,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技（武汉）股份有限公司（股票代码：03378）于2026年4月16日发布公告，披露回购股份事宜。\n公司于2026年4月16日在香港联交所场内回购20,100股H股，约占当日已发行股本0.015%。每股回购价格介乎28.48港元至30港元不等，总费用约为59.07万港元（折合590,668港元）。\n本次回购完成后，公司已发行股本变动为135,997,930股，库藏股数量增至220,900股。回购授权于2026年2月12日获股东大会通过，可回购股份总数上限为13,621,883股。公司确认已遵守所有适用法律法规及香港联交所上市规则的规定。\n本公告由董事长兼执行董事张发明签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627510882","title":"翰思艾泰-B于4月15日耗资约61.99万港元回购2.15万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627510882","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627510882?lang=zh_cn&edition=full","pubTime":"2026-04-16 08:44","pubTimestamp":1776300240,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　翰思艾泰-B（03378）公布，2026年4月15日耗资约61.99万港元回购2.15万股股份。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-04-16/doc-inhuryek2929105.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK1535","BK1173","03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165755962","title":"翰思艾泰-B：4月15日回购2.15万股，耗资约61.99万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1165755962","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165755962?lang=zh_cn&edition=full","pubTime":"2026-04-15 21:55","pubTimestamp":1776261352,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技（武汉）股份有限公司（股票名称“翰思艾泰-B”，股票代码03378）于2026年4月15日发布公告称，公司当日于香港联交所场内回购股份21,500股，占回购前已发行股本约0.016%。回购价格介乎每股28.2港元至29.8港元，总金额约61.99万港元。\n公告显示，完成回购后，公司已发行股本（不包括库藏股份）为136,018,030股，库藏股份数为200,800股。公司回购授权于2026年2月12日通过，可回购股份总数为13,621,883股。\n公司同时声明，本次股份回购已遵守香港联交所相关上市规则与适用法律规定。该公告由董事长兼执行董事张发明签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114098058","title":"翰思艾泰-B回购4.6万股股份，涉资约137.45万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1114098058","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114098058?lang=zh_cn&edition=full","pubTime":"2026-04-14 22:41","pubTimestamp":1776177718,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技（武汉）股份有限公司于2026年4月14日发布公告，披露公司于2026年4月13日在香港联交所场内回购46,000股H股，占已发行股本约0.034%。本次回购每股价格介乎港币28.68港元至30.70港元，涉资总额约1,374,486港元。公告显示，本次变动后公司已发行股本为136,063,030股，库藏股数量为155,800股，合计136,218,830股。公告提及，本次回购依据2026年2月12日获股东大会通过的购回授权，授权总数为13,621,883股。截至目前，公司已累计回购155,800股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108245263","title":"翰思艾泰-B回购2.37万股股份，总额约71.54万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1108245263","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108245263?lang=zh_cn&edition=full","pubTime":"2026-04-14 22:41","pubTimestamp":1776177694,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技（武汉）股份有限公司（股票代码：03378）于2026年4月14日公告，2026年4月10日在香港联交所场内回购2.37万股H股普通股，占公司已发行股本约0.017%。每股回购价介乎港币29.50元至30.66元，涉及总金额约71.54万港元。\n本次回购后，公司已发行股份数目从136,132,730股减少至136,109,030股，库藏股数量增至109,800股。\n回购依据于2026年2月12日获得通过的授权进行，该授权可回购股份总数为13,621,883股，截至目前已回购109,800股。公司确认已遵守香港联交所上市规则及相关法律法规。公告由董事长兼执行董事张发明签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171374321","title":"翰思艾泰-B回购2.35万股股份，总额约68.31万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1171374321","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171374321?lang=zh_cn&edition=full","pubTime":"2026-04-14 22:41","pubTimestamp":1776177678,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技（武汉）股份有限公司于2026年4月14日公告称，公司在香港联交所场内回购23,500股，占本次交易前已发行股份约0.017%。每股回购价介乎28.00港元至29.90港元，合计耗资约68.31万港元。公司于2026年2月12日通过相关股份购回授权，可回购总数为13,621,883股。截至本公告发布时，累计已回购179,300股，占授权当日已发行股份总数约0.1316%。公司确认本次股份购回严格遵守上市规则和相关法律规定。公告由董事长兼执行董事张发明签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627044737","title":"翰思艾泰-B(03378)4月14日耗资约68.31万港元回购2.35万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627044737","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627044737?lang=zh_cn&edition=full","pubTime":"2026-04-14 22:41","pubTimestamp":1776177663,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰思艾泰-B(03378)公布，2026年4月14日耗资约68.31万港元回购2.35万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428545.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1173","BK1535","03378","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117467447","title":"翰思艾泰-B：4月13日回购4.3万股，耗资约128.79万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117467447","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117467447?lang=zh_cn&edition=full","pubTime":"2026-04-13 20:46","pubTimestamp":1776084382,"startTime":"0","endTime":"0","summary":"翰思艾泰-B于2026年4月13日公告，公司在香港联交所场内回购43,000股H股，占当日回购前已发行股本约0.032%。本次回购每股价格区间为港币29.18元至30.7元，合计耗资约1,287,866港元。回购完成后，公司已发行股本总数仍为136,218,830股，其中持作库藏股149,100股，已发行股本则变动至136,069,730股。公司此前于2026年2月12日通过购回授权，授权可回购股份总数为13,621,883股，截至目前累计回购149,100股。公司强调，已就上述回购交易遵守香港联交所上市规则及相关法律规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627453986","title":"翰思艾泰-B(03378)4月13日耗资约128.79万港元回购4.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627453986","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627453986?lang=zh_cn&edition=full","pubTime":"2026-04-13 20:42","pubTimestamp":1776084155,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰思艾泰-B(03378)公布，2026年4月13日耗资约128.79万港元回购4.3万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427944.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","03378","BK1173","BK1535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626192646","title":"翰思艾泰-B(03378)将于2026年AACR年会发表四项壁报研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2626192646","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626192646?lang=zh_cn&edition=full","pubTime":"2026-04-10 19:41","pubTimestamp":1775821276,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰思艾泰-B 公布，公司四项创新药物研究成果将于2026年美国癌症研究协会年会以壁报形式展出。本届AACR年会将于2026年4月17日至22日在美国加利福尼亚州圣地亚哥会议中心举行。本次入选成果进一步验证公司的研发实力与创新能力。在临床前研究中，HX116展现出的活性优于其母体BsAb。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427247.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1535","BK1161","03378","BK1173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111745480","title":"翰思艾泰-B：4月10日回购2万股，耗资约60.26万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111745480","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111745480?lang=zh_cn&edition=full","pubTime":"2026-04-10 19:36","pubTimestamp":1775820993,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技（武汉）股份有限公司于2026年4月10日向香港联交所提交翌日披露报表，公告当日回购股份2万股，占公司已发行股本约0.015%。本次回购股份的每股价格区间介乎29.5港元至30.435238港元，合计耗资约60.26万港元。回购完成后，公司已发行股本数量变更为136,112,730股，库藏股数量为106,100股。购回授权于2026年2月12日获得通过，公司可在授权范围内累计购回最多13,621,883股，且此前已根据该授权累计购回106,100股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626413887","title":"翰思艾泰-B(03378)4月9日斥资3.21万港元回购1100股","url":"https://stock-news.laohu8.com/highlight/detail?id=2626413887","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626413887?lang=zh_cn&edition=full","pubTime":"2026-04-09 21:47","pubTimestamp":1775742453,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰思艾泰-B(03378)发布公告，于2026年4月9日，该公司斥资3.21万港元回购1100股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1426777.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","03378","BK1535","BK1173"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hanxbio.com/","stockEarnings":[{"period":"1week","weight":-0.0988},{"period":"1month","weight":0.0191},{"period":"3month","weight":0.6854},{"period":"6month","weight":-0.0994},{"period":"ytd","weight":0.8035}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0.0253},{"period":"3month","weight":-0.0288},{"period":"6month","weight":-0.007},{"period":"1year","weight":0.1857},{"period":"ytd","weight":0.0136}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"翰思艾泰生物医药科技（武汉）股份有限公司是一家主要从事肿瘤免疫疗法的研发的中国公司。该公司的产品管线有针对肿瘤学的临床阶段候选药物和临床前阶段候选药物，包括核心产品HX009及主要产品HX301及HX044，以及针对自身免疫和肿瘤市场的抗体偶联药物、双特异性抗体及单克隆抗体。HX009是一种自主研发的抗程序性细胞死亡蛋白1（PD-1）/信号调节蛋白α（SIRPα）双功能抗体融合蛋白。HX301是一种靶向集落刺激因子-1受体（CSF1R）、AMPK相关蛋白激酶5（ARK5）、FMS样酪氨酸激酶3（FLT-3）及细胞周期蛋白依赖性激酶4/6（CDK4/6）等关键通路的多靶点激酶抑制剂。HX044为一种新型双重功能抗细胞毒性T淋巴细胞相关蛋白4（CTLA-4）抗体SIRPα融合蛋白。","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":0.005427},{"month":2,"riseRate":0.411765,"avgChangeRate":0.008835},{"month":3,"riseRate":0.352941,"avgChangeRate":-0.021319},{"month":4,"riseRate":0.705882,"avgChangeRate":0.100651},{"month":5,"riseRate":0.352941,"avgChangeRate":0.046508},{"month":6,"riseRate":0.470588,"avgChangeRate":-0.00883},{"month":7,"riseRate":0.470588,"avgChangeRate":0.004276},{"month":8,"riseRate":0.470588,"avgChangeRate":-0.031033},{"month":9,"riseRate":0.588235,"avgChangeRate":-0.013577},{"month":10,"riseRate":0.75,"avgChangeRate":0.019136},{"month":11,"riseRate":0.625,"avgChangeRate":0.009468},{"month":12,"riseRate":0.625,"avgChangeRate":0.056179}],"exchange":"SEHK","name":"翰思艾泰-B","nameEN":"HANXBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"翰思艾泰-B(03378)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供翰思艾泰-B(03378)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"翰思艾泰-B,03378,翰思艾泰-B股票,翰思艾泰-B股票老虎,翰思艾泰-B股票老虎国际,翰思艾泰-B行情,翰思艾泰-B股票行情,翰思艾泰-B股价,翰思艾泰-B股市,翰思艾泰-B股票价格,翰思艾泰-B股票交易,翰思艾泰-B股票购买,翰思艾泰-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"翰思艾泰-B(03378)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供翰思艾泰-B(03378)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}